Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19375973 | FRAGMENTING RNA:DNA HYBRIDS | October 2025 | January 2026 | Allow | 3 | 0 | 0 | Yes | No |
| 19361770 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | October 2025 | March 2026 | Allow | 5 | 1 | 0 | No | No |
| 19318311 | METHODS FOR DETECTING INTERCELLULAR INTERACTIONS OF CELLS IN A COMPARTMENT OF A FLUIDIC DEVICE | September 2025 | January 2026 | Allow | 5 | 1 | 0 | Yes | No |
| 19318315 | METHODS FOR INCUBATING AND ANALYZING A CELL IN A COMPARTMENT OF A FLUIDIC DEVICE | September 2025 | January 2026 | Allow | 5 | 1 | 0 | Yes | No |
| 19311988 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | August 2025 | March 2026 | Allow | 6 | 1 | 0 | No | No |
| 19306722 | METHOD OF RAPID EXTRACTION OF DNA FROM SALIVA AND QPCR AMPLIFICATION OF GROUP A STREPTOCOCCUS DNA | August 2025 | February 2026 | Allow | 6 | 1 | 0 | No | No |
| 19297604 | Biomarker for Detecting and Treating Type II Diabetes | August 2025 | February 2026 | Allow | 6 | 1 | 0 | No | No |
| 19295122 | NANOPORE-BASED ANALYSIS OF ANALYTES | August 2025 | December 2025 | Allow | 4 | 0 | 0 | No | No |
| 19294044 | METHODS FOR IMAGING AND ANALYZING A CELL IN A COMPARTMENT OF A FLUIDIC DEVICE | August 2025 | January 2026 | Allow | 6 | 1 | 0 | Yes | No |
| 19283119 | SYSTEMS AND METHODS FOR TRANSFER OF REAGENTS BETWEEN DROPLETS | July 2025 | March 2026 | Allow | 7 | 1 | 1 | Yes | No |
| 19278614 | METHODS FOR ENCLOSING AND ANALYZING A CELL IN A FLUIDIC DEVICE | July 2025 | February 2026 | Allow | 7 | 1 | 0 | Yes | No |
| 19268022 | LINKED LIGATION | July 2025 | August 2025 | Allow | 1 | 0 | 0 | No | No |
| 19268839 | SCHEDULING METHOD FOR DAILY ECOLOGICAL FLOW VARIATION OF RIVER REACH BASED ON FISH HABITAT SUITABILITY OVERLAP RATE | July 2025 | February 2026 | Abandon | 7 | 1 | 0 | No | No |
| 19258562 | Context-Specific Tumor-Only Mutation Classification | July 2025 | February 2026 | Allow | 8 | 1 | 0 | Yes | No |
| 19252300 | ALLELE, MOLECULAR MARKER, AND PRIMER PAIR OF RICE HPS1 GENE, AND APPLICATIONS THEREOF | June 2025 | December 2025 | Allow | 6 | 2 | 0 | Yes | No |
| 19251197 | METHODS AND SYSTEMS FOR GENETIC ANALYSIS | June 2025 | January 2026 | Allow | 7 | 1 | 1 | No | No |
| 19249710 | SEQUENCING METHODS WITH PARTITIONING | June 2025 | September 2025 | Allow | 3 | 1 | 0 | No | No |
| 19241820 | METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME | June 2025 | February 2026 | Allow | 8 | 1 | 0 | Yes | No |
| 19240880 | METHODS AND COMPOSITIONS FOR ISOLATING AN ANALYTE | June 2025 | August 2025 | Allow | 2 | 0 | 0 | No | No |
| 19236454 | GENERATION OF PHASED READ-SETS FOR GENOME ASSEMBLY AND HAPLOTYPE PHASING | June 2025 | January 2026 | Allow | 8 | 1 | 0 | No | No |
| 19230686 | SYSTEMS AND METHODS FOR ENCAPSULATION AND MULTI-STEP PROCESSING OF BIOLOGICAL SAMPLES | June 2025 | March 2026 | Allow | 9 | 2 | 0 | No | No |
| 19230110 | METHOD FOR DETECTING MOLECULAR CHARACTERISTIC OF GENE-EDITED DISEASE-RESISTANT PIG AND USE THEREOF | June 2025 | December 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 19228005 | ANALYSIS OF A POLYNUCLEOTIDE VIA A NANOPORE SYSTEM | June 2025 | October 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 19220155 | METHOD FOR DETECTING BI-ALLELIC GENE EDITED CELLS BASED ON CRISPR/CAS12A TECHNOLOGY | May 2025 | July 2025 | Allow | 2 | 0 | 0 | Yes | No |
| 19212481 | METHOD FOR MAKING A PHYSICAL MAP OF BINDING EVENTS THAT ARE ON OR ON CELLS | May 2025 | July 2025 | Allow | 1 | 0 | 0 | No | No |
| 19212398 | CHROMATIN PROFILING COMPOSITIONS AND METHODS | May 2025 | November 2025 | Allow | 6 | 1 | 0 | No | No |
| 19212523 | KNEE ARTHROPLASTY METHOD | May 2025 | October 2025 | Allow | 5 | 1 | 0 | No | No |
| 19207265 | REASONING FROM SUPERVISED FINE TUNING OF LANGUAGE FUSION MODELS FOR AI-BASED PROTEIN AND DRUG DESIGN | May 2025 | September 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 19202222 | METHODS FOR PREPARING 5'-END LIGATION-BASED ssDNA-SPECIFIC SEQUENCING LIBRARIES | May 2025 | December 2025 | Allow | 7 | 2 | 0 | No | No |
| 19201039 | METHODS FOR EARLY DETECTION OF CANCER | May 2025 | September 2025 | Allow | 4 | 1 | 0 | No | No |
| 19192017 | DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETS | April 2025 | October 2025 | Allow | 6 | 1 | 1 | Yes | No |
| 19188704 | Nucleotide Analogs for Efficient DNA and RNA Amplification | April 2025 | August 2025 | Allow | 4 | 0 | 0 | No | No |
| 19188895 | DIRECT-TO-LIBRARY METHODS, SYSTEMS, AND COMPOSITIONS | April 2025 | February 2026 | Allow | 10 | 1 | 0 | No | No |
| 19181901 | METHODS AND SYSTEMS FOR DETECTING A PRIMARY DISEASE | April 2025 | September 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19180024 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | April 2025 | October 2025 | Allow | 7 | 1 | 1 | No | No |
| 19178769 | CONDITIONAL MULTICAPITATE NEURAL NETWORKS FOR AI-BASED PROTEIN AND DRUG DESIGN | April 2025 | August 2025 | Allow | 4 | 3 | 0 | Yes | No |
| 19178472 | PERSONALIZED WELLNESS SYSTEMS AND METHODS OF USE | April 2025 | September 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19177401 | DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES | April 2025 | August 2025 | Allow | 4 | 1 | 0 | No | No |
| 19175905 | RECURSIVE TRANSFORMERS FOR AI-BASED PROTEIN-PROTEIN INTERACTION AND DRUG DESIGN | April 2025 | August 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19172702 | Products for Protein Analyte Detection Assays Using Antibodies | April 2025 | December 2025 | Allow | 8 | 2 | 1 | Yes | No |
| 19172703 | Nucleic Acid Reporter Molecules for Massively Parallel DNA Sequencing | April 2025 | October 2025 | Allow | 6 | 1 | 1 | Yes | No |
| 19169801 | SAMPLE PREPARATION METHOD | April 2025 | October 2025 | Allow | 7 | 2 | 0 | No | No |
| 19098389 | MOLECULE DESIGN WITH MULTI-OBJECTIVE OPTIMIZATION OF PARTIALLY ORDERED, MIXED-VARIABLE MOLECULAR PROPERTIES | April 2025 | November 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 19097444 | METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES | April 2025 | January 2026 | Allow | 10 | 1 | 0 | Yes | No |
| 19092749 | MACHINE LEARNING ENABLED PREDICTION OF MOLECULAR STRUCTURES AND PROPERTIES | March 2025 | March 2026 | Allow | 11 | 2 | 0 | Yes | No |
| 19093126 | Methods and Systems for Machine-Learning Based Molecule Generation and Scoring | March 2025 | January 2026 | Allow | 10 | 2 | 0 | Yes | No |
| 19091172 | SYSTEMS AND METHODS FOR SELECTIVE DNA MULTIPLE DISPLACEMENT AMPLIFICATION OF A DNA MIXTURE; | March 2025 | January 2026 | Allow | 10 | 2 | 0 | Yes | No |
| 19091700 | LIQUID LEVEL AND FLOW RATE DETECTION WITHIN A CELL PROCESSING SYSTEM | March 2025 | October 2025 | Allow | 7 | 1 | 0 | No | No |
| 19089212 | HEALTH RISK MONITORING METHOD AND APPARATUS FOR SUBSURFACE SOIL POLLUTION OF IMPERVIOUS SURFACE IN URBAN FACTORIES | March 2025 | November 2025 | Abandon | 8 | 1 | 0 | No | No |
| 19088591 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | March 2025 | November 2025 | Allow | 8 | 1 | 0 | No | No |
| 19088508 | METHODS FOR DETECTING NUCLEIC ACID MOLECULES IN CELLS | March 2025 | February 2026 | Allow | 11 | 2 | 0 | No | No |
| 19087449 | CAM-GUIDED TRANSFORMERS FOR AI-BASED PROTEIN AND DRUG DESIGN | March 2025 | September 2025 | Allow | 6 | 2 | 0 | Yes | Yes |
| 19083413 | PRIMER SET OF MYCOBACTERIUM TUBERCULOSIS BASED ON SPECIFIC HRCA ISOTHERMAL AMPLIFICATION AND AN APPLICATION THEREOF | March 2025 | July 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 19083328 | METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES | March 2025 | October 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 19082509 | LINKED LIGATION | March 2025 | July 2025 | Allow | 4 | 0 | 0 | No | No |
| 19082485 | LINKED LIGATION | March 2025 | May 2025 | Allow | 2 | 0 | 0 | No | No |
| 19079081 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | March 2025 | September 2025 | Allow | 7 | 1 | 0 | Yes | No |
| 19073932 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | March 2025 | June 2025 | Allow | 4 | 0 | 0 | Yes | No |
| 19074001 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | March 2025 | July 2025 | Allow | 4 | 0 | 0 | No | No |
| 19073665 | METHODS FOR USING MOSAICISM IN NUCLEIC ACIDS SAMPLED DISTAL TO THEIR ORIGIN | March 2025 | August 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 19072459 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | March 2025 | August 2025 | Allow | 6 | 1 | 0 | No | No |
| 19072478 | TREATMENT OF DEPRESSION USING MACHINE LEARNING | March 2025 | October 2025 | Allow | 8 | 1 | 0 | Yes | No |
| 19072452 | TREATMENT OF DEPRESSION USING MACHINE LEARNING | March 2025 | October 2025 | Allow | 8 | 1 | 0 | Yes | No |
| 19072469 | TREATMENT OF DEPRESSION USING MACHINE LEARNING | March 2025 | August 2025 | Allow | 5 | 1 | 0 | No | No |
| 19070259 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | March 2025 | April 2025 | Allow | 2 | 1 | 0 | No | No |
| 19069064 | ANALYSIS OF NUCLEIC ACID SEQUENCES | March 2025 | March 2026 | Abandon | 12 | 2 | 0 | Yes | No |
| 19064793 | SELF-CONTAINED BIOLOGICAL ANALYSIS | February 2025 | August 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19064276 | Methods and Systems for Determining Proportions of Distinct Cell Subsets | February 2025 | January 2026 | Allow | 10 | 1 | 1 | No | No |
| 19062053 | METHOD FOR DETERMINING ECOLOGICAL FLOW PROCESS AND WATER TEMPERATURE PROCESS OF HABITAT REQUIREMENTS OF FULL LIFE HISTORY OF FISH | February 2025 | August 2025 | Allow | 6 | 1 | 0 | No | No |
| 19060201 | SINGLE-STRANDED END PRESERVING ADAPTORS | February 2025 | March 2026 | Allow | 13 | 2 | 1 | Yes | No |
| 19059102 | CATALYTIC DE-CROSSLINKING OF SAMPLES FOR IN SITU ANALYSIS | February 2025 | September 2025 | Allow | 6 | 1 | 0 | No | No |
| 19057774 | Methods and Systems for Determining Proportions of Distinct Cell Subsets | February 2025 | January 2026 | Allow | 11 | 1 | 1 | Yes | No |
| 19057757 | Methods and Systems for Determining Proportions of Distinct Cell Subsets | February 2025 | March 2026 | Allow | 13 | 2 | 1 | Yes | No |
| 19057786 | Systems and Methods for Analyzing Mixed Cell Populations | February 2025 | December 2025 | Allow | 10 | 1 | 0 | Yes | No |
| 19056112 | METHODS AND SYSTEMS FOR GENETIC ANALYSIS | February 2025 | November 2025 | Allow | 9 | 1 | 1 | No | No |
| 19053925 | IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULES | February 2025 | June 2025 | Allow | 4 | 1 | 0 | No | No |
| 19049943 | DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETS | February 2025 | September 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 19048060 | MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOF | February 2025 | May 2025 | Allow | 4 | 0 | 0 | No | No |
| 19047506 | PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINS | February 2025 | July 2025 | Allow | 5 | 1 | 0 | No | No |
| 19044599 | COMPOSITIONS AND METHODS FOR EVALUATING GENOMIC ALTERATIONS | February 2025 | August 2025 | Allow | 6 | 1 | 1 | Yes | No |
| 19041629 | CELL-FREE METHOD OF PRODUCING SYNTHETIC CIRCULAR NUCLEIC ACID | January 2025 | September 2025 | Allow | 7 | 1 | 1 | Yes | No |
| 19037106 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR AUTOMATED ASSESSMENT OF ASEPTIC TECHNIQUE OF COMPOUNDING IN A COMPOUNDING HOOD | January 2025 | January 2026 | Allow | 11 | 1 | 1 | No | No |
| 19035409 | MYC AMPLIFICATION DRIVES RESISTANCE TO PAN-RAS INHIBITORS IN PANCREATIC CANCER | January 2025 | February 2026 | Allow | 13 | 1 | 1 | No | No |
| 19031343 | DRUG DESIGN METHOD BASED ON AUTOREGRESSIVE MODEL | January 2025 | August 2025 | Allow | 7 | 1 | 0 | No | No |
| 19029558 | METHODS AND SYSTEMS FOR ANALYZING NUCLEIC ACID MOLECULES | January 2025 | October 2025 | Allow | 9 | 1 | 0 | Yes | No |
| 19028873 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | January 2025 | October 2025 | Allow | 9 | 1 | 0 | No | No |
| 19028776 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | January 2025 | October 2025 | Allow | 9 | 1 | 0 | No | No |
| 19029171 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | January 2025 | October 2025 | Allow | 9 | 1 | 0 | No | No |
| 19029732 | DESIGN AND SYNTHESIS OF NOVEL DISULFIDE LINKER BASED NUCLEOTIDES AS REVERSIBLE TERMINATORS FOR DNA SEQUENCING BY SYNTHESIS | January 2025 | August 2025 | Allow | 7 | 0 | 1 | No | No |
| 19028468 | PLATFORM FOR DISCOVERY AND ANALYSIS OF THERAPEUTIC AGENTS | January 2025 | November 2025 | Allow | 10 | 2 | 0 | Yes | No |
| 19027603 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | January 2025 | June 2025 | Allow | 5 | 1 | 1 | No | No |
| 19027486 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | January 2025 | August 2025 | Allow | 7 | 1 | 0 | No | No |
| 19027542 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | January 2025 | June 2025 | Allow | 5 | 1 | 1 | No | No |
| 19029541 | METHODS OF DETECTING AND ENRICHING CIRCULATING TUMOR DNA | January 2025 | May 2025 | Allow | 4 | 1 | 0 | No | No |
| 19025566 | METHODS AND SYSTEMS FOR ANALYZING NUCLEIC ACID MOLECULES | January 2025 | October 2025 | Allow | 9 | 1 | 0 | No | No |
| 19025994 | METHOD FOR TESTING LEUKOCYTES FOR A DISEASE STATE | January 2025 | October 2025 | Allow | 9 | 1 | 1 | Yes | No |
| 19025868 | METHOD FOR DETERMINING PROPERTIES OF FLOWING LEUKOCYTES | January 2025 | October 2025 | Allow | 9 | 1 | 1 | Yes | No |
| 19020482 | GENETIC VARIANT DETECTION BASED ON MERGED AND UNMERGED READS | January 2025 | October 2025 | Allow | 9 | 2 | 0 | No | No |
| 19016998 | METHODS AND SYSTEMS FOR DROPLET-BASED SINGLE CELL BARCODING | January 2025 | November 2025 | Abandon | 10 | 0 | 1 | No | No |
| 19014935 | METHOD AND KIT FOR GENOTYPING OF MULTI-SYSTEM RED BLOOD CELL (RBC) BLOOD GROUP BASED ON NEXT-GENERATION SEQUENCING (NGS) | January 2025 | June 2025 | Allow | 6 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for group 1680.
With a 55.8% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Group 1680 is part of Technology Center 1600. This group has examined 6,491 patent applications in our dataset, with an overall allowance rate of 79.9%. Applications typically reach final disposition in approximately 46 months.
Applications in Group 1680 receive an average of 2.55 office actions before reaching final disposition. The median prosecution time is 46 months.
This group-level data aggregates statistics across multiple art units. For more targeted prosecution strategies, review the individual art unit and examiner statistics within this group.
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.